Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Shames
PL02.07 IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA04.10 Comprehensive Peripheral Blood Immunophenotyping and T-Cell Clonal Analysis During Neoadjuvant Immunotherapy With Atezolizumab in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
OA05.07 IMpower132: PFS and Safety Results With 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Study: Atezolizumab Improves Survival in SCLC
Cancer Discovery
Oncology
First-Line Atezolizumab OK'd for SCLC
Cancer Discovery
Oncology
SCLC – Vergleichbare Wirksamkeit Von Cisplatin Und Carboplatin
Pneumologie
Medicine
Pulmonary
Respiratory Medicine
Pharmacokinetics of Carboplatin and Etoposide in a Hemodialysis Patient With Small Cell Lung Carcinoma.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Carboplatin Plus Etoposide Induced a Complete Response in a Hemodialysis Patient With Limited Stage Small Cell Lung Cancer–a Case Report and Literature Review–
Nihon Toseki Igakkai Zasshi
P1.01-83 IMpower150: Impact of Chemotherapy Cycles in 1L Metastatic NSCLC in Patients Treated With Atezolizumab + Bevacizumab
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Addition of Lenalidomide to Rituximab, Ifosfamide, Carboplatin, Etoposide (RICER) in First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
British Journal of Haematology
Hematology
P1.12-11 2010 – 2015 Extensive Stage SCLC Diagnoses in a Canadian Institution: Baseline Characteristics That Impact on the Overall Survival
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
